Students
Tuition Fee
EUR 900
Per course
Start Date
2026-06-01
Medium of studying
Duration
6 weeks
Details
Program Details
Degree
Courses
Major
Biomedical Sciences | Clinical Research | Health Informatics
Area of study
Health
Timing
Part time
Course Language
English
Tuition Fee
Average International Tuition Fee
EUR 900
Intakes
Program start dateApplication deadline
2026-06-01-
2027-06-01-
About Program

Program Overview


Introduction to Real World Data in Cancer Clinical Research - Module BM6053

Brief Description

The purpose of this module is to upskill professionals who interact, manage, curate, or analyse cancer electronic health data and/or are engaged in cancer real-world evidence research. Real-world data describes health data collected outside of randomised controlled trials, typically as part of routine clinical practice. If analysed appropriately, real-world data can generate real-world evidence, which can offer insights into disease and the benefits and risks of therapeutic interventions as observed in a real-life environment.


Course Details

  • Course Code(s): BM6053
  • Available: Part-Time
  • Intake: Summer
  • Course Start Date: Summer 2026
  • Duration: 6 Weeks
  • Award: University Certificate of Study
  • Faculty: Education and Health Sciences
  • Course Type: Professional/Flexible

Fees

  • 900 for EU and Non-EU students
  • Further information on fees and payment of fees is available from the Student Fees Office.

Programme Content

Learning Outcomes

On successful completion of this module, students will be able to:


  • Critically assess secondary use of cancer data for research.
  • Evaluate existing and emerging international clinical data standards for secondary use and analysis of cancer data, the use of vocabularies, ontologies, and organisations that govern data standards.
  • Critically evaluate research use of cancer health data, differentiating data use in clinical practice, emerging cancer clinical trial designs, and real-world evidence research.
  • Recommend strategies and best practices in secure sharing data for secondary analysis.
  • Conduct a comprehensive review of emerging literature on the secondary use of cancer patient healthcare imaging, genetic, or genomics data and write a report that communicates these data and interprets the findings.
  • Display a professional commitment to ethical data practice.
  • Demonstrate an appreciation of the pace of technological and computational research advances in cancer and gain an insight into the potential risks and benefits of federated data sharing and analysis.
  • Present a patient record as it might be presented to a molecular tumour board.

Assessment

There is no final exam for this module. Students will be assessed through continuous skill-based assignments.


Weekly Time Commitment

12 hours


Entry Requirements

Applicants must have a minimum Level 8 honours degree, at minimum second-class honours (NFQ or other internationally recognised equivalent) in a clinical, healthcare, science, or computing or related discipline, or a minimum of 5 years relevant professional experience in healthcare informatics or related setting.


Other Funding

Find further information on funding and scholarships.


See More
How can I help you today?